<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE307nnn/GSE307956/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307956</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>DJ-1 alleviates high glucose-induced podocyte injury via activating ERK1/2 signaling</name><description>Diabetic nephropathy (DN) is one of the most common complications of diabetes. DJ-1 has been reported to participate in the response to renal ischemia/reperfusion (I/R) injury. However, the underlying mechanisms of DJ-1 in the regulation of high glucose-induced renal injury remain obscure. In this study, we performed RNA-seq to explore the function of high glucose on human podocyte cells (HPC), and found that high glucose widely regulated a variety of signaling pathways, including cell growth and death, signal transduction, etc. Furthermore, we found that DJ-1 was decreased in the high glucose conditions and DJ-1 could attenuate the high glucose-induced HPC apoptosis. Mechanically, overexpression of DJ-1 increased the phosphorylation of ERK1/2 (p-ERK1/2) and then mediated the transport of p-ERK1/2 from the cytoplasm to the nucleus. Furthermore, the accumulation of p-ERK1/2 in the nucleus activated the ERK1/2 pathway and enhanced the expression of NF-κB p65 and AP-1, which inhibited the apoptosis of HPC in the high glucose milieu. In conclusion, our study demonstrated that high glucose decreased DJ-1 expression in HPC and that overexpression of DJ-1 attenuated the apoptosis of HPC in high glucose conditions via enhancing the ERK1/2 pathway and the expression of NF-κB p65 and AP-1. Our study provides a novel mechanism by which DJ-1 alleviates high glucose-induced podocyte injury.</description><dates><publication>2026/04/22</publication></dates><accession>GSE307956</accession><cross_references><GSM>GSM9234609</GSM><GSM>GSM9234606</GSM><GSM>GSM9234605</GSM><GSM>GSM9234608</GSM><GSM>GSM9234607</GSM><GSM>GSM9234602</GSM><GSM>GSM9234601</GSM><GSM>GSM9234604</GSM><GSM>GSM9234603</GSM><GPL>34284</GPL><GSE>307956</GSE><taxon>Homo sapiens</taxon><PMID>[41996356]</PMID></cross_references></HashMap>